Print this page
 
Sept 8, 2016
Biolux Research and the Schulman Study Group announce a partnership promoting Light Accelerated Orthodontics™

VANCOUVER, B.C., CANADA Sept 8, 2016
Biolux Research, developer of OrthoPulse®, is pleased to announce the renewal of its partnership with the Schulman Study Group in an agreement to promote and provide innovative photobiomodulation products to Schulman orthodontic practices and patients.

[click here to download PDF]
Sept. 16, 2016
Biolux Research announces Irish distribution agreement with Promed for OrthoPulse®

VANCOUVER, B.C., CANADA Sept. 16, 2016
Biolux Research, designer and developer of Light Accelerated Orthodontics™ technology and products, is excited to announce it has reached agreement with Promed, for developing the Irish market.

[click here to download PDF]
Sept. 30, 2016
Biolux Research to exhibit OrthoPulse® at annual sessions for Northeast Society of Orthodontists and Pacific Coast Society of Orthodontists

VANCOUVER, B.C., CANADA Sept. 30, 2016
Biolux Research is pleased to announce that it will be exhibiting its OrthoPulse® product at the NESO and PCSO Annual Meetings this October.

[click here to download PDF]
Jul 31, 2015
Biolux Research announces receipt of 510(k) marketing clearance for OrthoPulse™ from the US Food and Drug Administration

VANCOUVER, B.C., CANADA July 31, 2015
Biolux Research, designer and developer of Light Accelerated Orthodontics™ technology and products, is excited to announce the receipt of 510(k) marketing clearance for OrthoPulse™ from the US Food and Drug Administration on July 24, 2015.

[click here to download PDF]
Apr 1, 2015
Biolux Research to showcase OrthoPulse™ technology at the 2015 annual session of the American Association of Orthodontists (AAO)

VANCOUVER, B.C., CANADA April 1, 2015
Biolux Research, designer and developer of Light Accelerated Orthodontics™ technology and products, is thrilled to be an exhibitor at the 2015 Annual Session of the American Association of Orthodontists (AAO) for the first time.

[click here to download PDF]
Mar 6, 2015
Biolux Research announces that OrthoPulse™ receives regulatory approval in Australia and New Zealand.

VANCOUVER, B.C., CANADA March 6, 2015
Biolux Research, developer of Light Accelerated Orthodontics™ technology and products, is proud to announce that its premier product, OrthoPulse™, has received two new regulatory approvals. These most recent approvals, in Australia and New Zealand, will enable doctors in those countries to offer this groundbreaking acceleration technology to their orthodontic patients.

[click here to download PDF]
November 21, 2014
Biolux Research announces that OrthoPulse™ receives regulatory approval in Canada.

VANCOUVER, B.C., CANADA November 21, 2014
Biolux Research, developer of Light Accelerated Orthodontics™ technology and products, is proud to announce that its innovative new product, OrthoPulse™, has received a Medical Device License from Health Canada and is now commercially available in Canada. The device was approved as a Class 2 medical device according to the Canadian Medical Device Regulations. In addition, the Company recently updated its ISO 13485 scope of operations to include devices for use in orthodontics.

[click here to download PDF]
September 25, 2014
Biolux Research announces that OrthoPulse™ receives regulatory approval in Europe.

VANCOUVER, B.C., CANADA September 25, 2014
Biolux Research, developer of Light Accelerated Orthodontics™ technology and products, is proud to announce that its innovative new product, OrthoPulse™, has received CE mark approval and is now commercially available for all European countries that recognize CE mark. The device was approved as a Class 2A medical device via the Medical Device Directive 93/42/EEC, Annex V by London-based British Standards Institute. Biolux is also pleased to announce the launch of a new product website www.orthopulse.com which provides all product, technology, and clinical information, a catalog and shopping cart, plus many new patient and doctor-focused features.

[click here to download PDF]
May 28, 2014
Biolux Research announces OrthoPulse™ beta evaluation program with the Schulman Study Group.

VANCOUVER, B.C., CANADA May 28, 2014
Biolux Research, developer of Light Accelerated Orthodontics™ technology and products, is pleased to team up with the Schulman Study Group to beta test the new OrthoPulse™ product. The intraoral device incorporates proprietary photobiomodulation technology and is designed to be used with any form of orthodontic mechanics to significantly reduce patient treatment timelines.

[click here to download PDF]
May 2, 2014
Biolux Research announces Celestica HealthTech as its manufacturing partner for OrthoPulse™.

VANCOUVER, B.C., CANADA May 2, 2014
Biolux Research, developer of Light Accelerated Orthodontics™ technology and products, is pleased to announce the appointment of Celestica HealthTech as its manufacturing partner for commercialization of the new OrthoPulse™ product for significantly accelerating orthodontic tooth movement and reducing treatment timelines.

[click here to download PDF]
April 17, 2014
Biolux Research announces a new clinical trial to evaluate the use of photobiomodulation during clear aligner orthodontic treatment.

VANCOUVER, B.C., CANADA April 17, 2014
Biolux Research, developer of Light Accelerated Orthodontics™ technology and products, is pleased to announce the start of a new clinical trial to evaluate the efficacy of combining Biolux-developed and proprietary photobiomodulation technology with clear aligners during orthodontic treatment. Clear aligners are an alternate approach to orthodontic treatment, and are growing in popularity because of the cosmetic benefit as compared to traditional brackets and wires. By combining clear aligners and the intraoral Biolux technology to move teeth faster, patients may be able to achieve both the cosmetic benefit and significant reductions in treatment timeline. The Biolux technology includes a soft silicone intraoral tray with embedded photobiomodulation technology, which the patient takes home and self treats with a short daily treatment.

[click here to download PDF]
April 2, 2014
Biolux Research announces two AAO general session presentations in New Orleans by Dr. Chung How Kau and Dr. Tim Shaughnessy

VANCOUVER, B.C., CANADA April 2, 2014
Biolux Research,the developer ofLight Accelerated Orthodontics™ technology and products, is pleased to announce two presentations on faster effective orthodontics and photobiomodulation in clinical orthodontic practice at the New Orleans AAO April 28, 2014.

[click here to download PDF]
March 5, 2014
Biolux Research Announces appointment of vice president of global sales and marketing for commericialization of orthopulse™

VANCOUVER, B.C., CANADA March 5, 2014
Biolux Research, the developer of Light Accelerated Orthodontics™ technology and products, is pleased to announce the key appointment of orthodontic industry veteran John Nabors as Vice President of Global Sales and Marketing. Mr. Nabors’ primary responsibility is the commercialization of the OrthoPulse™, a new product developed to significantly accelerate orthodontic tooth movement and reduce treatment timelines. The OrthoPulse™ product is planned for commercial soft-launch in mid 2014 in select target markets within Canada and Europe, followed by introduction into other markets.

[click here to download PDF]
October 7, 2013
Biolux Research Announces the completion of a successful new clinical study for light accelerated implantology

VANCOUVER, B.C., CANADA / October 7, 2013
- Biolux Research Announces publication of clinical trial results for extra-oral light accelerated orthodontics

[click here to download PDF]
July 25, 2013
Biolux Research Announces the completion of a successful new clinical study for light accelerated implantology

VANCOUVER, B.C., CANADA / July 25, 2013
- Biolux Research Ltd. is pleased to announce the successful completion of a new clinical study using a shorter, more efficient, photobiomodulation treatment protocol to increase implant stability after surgery.

[click here to download PDF]
April 29, 2013
Biolux Research Announces pilot study results and development of a new intraoral product for light accelerated orthodontics

VANCOUVER, B.C., CANADA / April 29, 2013
- Biolux Research Ltd. is very pleased to announce that the company has committed to development of a new photobiomodulation product ( OrthoPulse iO ) for accelerating orthodontic treatment. To date the company has developed extraoral photobiomodulation technology and devices for dental applications involving bone regeneration, and is now focusing on an intraoral approach for orthodontics. The main benefits of intraoral photobiomodulation are increased clinical efficacy and a much shorter daily treatment session (a few minutes per arch), both of which are expected to lead to significant market acceptance and patient compliance.

[click here to download PDF]
March 20, 2013
Biolux Research Announces significant research findings on light accelerated orthodontics at IADR/AADR General Session 2013

VANCOUVER, B.C., CANADA / March 20, 2013
- Biolux Research Ltd. is very pleased to announce that two sponsored research studies on important photobiomodulation results will be presented at the upcoming International Association of Dental Research / American Association of Dental Research General Session and Exhibition in Seattle Washington Mar 20 23, 2013. These presentations include clinical evaluation of both efficacy and safety of Biolux-patented Light Accelerated Orthodontics technology and devices.

[click here to download PDF]
February 4, 2013
Biolux Research Announces regional distribution partner for Middle East and North Africa

VANCOUVER, B.C., CANADA / Feb. 4, 2013
- Biolux Research Ltd. Is very pleased to announce a partnership with MAC International Medical Solutions LLC of Dubai, UAE, for the distribution of the OsseoPulse bone regeneration system for use in implantology and dental surgery. The distribution agreement includes the regional territory of the Middle East and North Africa (MENA), and is for a three year term.

[click here to download PDF]
November 19, 2012
Biolux Research Announces sponsorship of inaugural rapid orthodontics symposium at AEEDCc 2013 in Dubai, UAE

VANCOUVER, B.C., CANADA / Nov. 19, 2012
- Biolux Research Ltd. is pleased to announce that it is sponsoring the inaugural Rapid Orthodontics Symposium planned in conjunction with the 17th edition of the UAE International Dental Conference & Arab Dental Exhibition (AEEDC) in Dubai, UAE on February 6, 2013. The symposium is designed to bring together the leading experts in the world on various techniques and technologies related to accelerating orthodontic tooth movement, improving treatment efficiency, and reducing treatment timelines. The event is being developed by Dr. Donald J. Ferguson, Professor and Dean, European University College, Dubai Healthcare City, UAE.

[click here to download PDF]
July 25, 2012
Biolux Research Announces Appointment of Dr. Chung How Kau to Clinical and Scientific Advisory Board

VANCOUVER, B.C., CANADA / Jul. 25, 2012
- Biolux Research Ltd. is pleased to announce the appointment of Chung How Kau, BDS, MScD, MBA, PhD, MOrth, FDS, FFD (Ortho) FAMS (Ortho), Cert (Ortho) to our clinical and scientific advisory board. Dr. Kau is Chairman and Professor at the Department of Orthodontics, University of Alabama at Birmingham, USA, and is an accomplished orthodontist, researcher, educator, author, and international speaker in the orthodontics world. He has trained and worked previously at the National University in Singapore, at Cardiff University and at the University of Texas Health Science Center (see biography at http://www.dental.uab.edu/departments-and-programs/orthodontics/chung-h-kau.html).

[click here to download PDF]
June 5, 2012
Biolux Research Hosts Second Annual Light Accelerated Orthodontics and Bone Regeneration Clinical and Scientific Conference.

VANCOUVER, B.C., CANADA / Jun. 5, 2012
- Biolux Research is pleased to announce that it hosted its 2nd annual clinical and scientific conference on Light Accelerated Orthodontics and Bone Regeneration, May 3-4 in Waikiki, Hawaii. This exclusive event featured a keynote speaker who is a world leader in cardiac and stroke photobiomodulation research, and presentations by key investigators participating in Biolux-sponsored studies, ranging from cellular-level research through to complete orthodontic cases. The meeting was designed to share new research on the mechanisms and clinical effects of OrthoPulse™ photobiomodulation technology, and promote collaboration and discussion of the impact of light treatment on the practice of orthodontics.

[click here to download PDF]
March 13, 2012
Biolux Research announces start of two additional clinical trials for light-accelerated orthodontics

VANCOUVER, B.C., CANADA / Mar. 13, 2012
- Biolux Research Ltd. is pleased to announce the start of two new controlled and randomized clinical trials to investigate the effects of OrthoPulse phototherapy technology on orthodontic treatment and overall timelines. Both studies are designed to evaluate the effect of light treatment during the complete whole mouth orthodontic treatment protocol in treated groups compared to control groups. These clinical trials are also designed to evaluate any impact of light treatment on compliance (patient acceptance of treatment), patient lifestyle, post-adjustment discomfort, and any change in levels of medication.

[click here to download PDF]
January 20, 2012
Biolux Research Announces Allowance of Key Light Therapy Patent and Filing of New Light Accelerated Orthodontics Patent Applications

VANCOUVER, B.C., CANADA / Jan. 20, 2012
- Biolux Research Ltd. is pleased to announce that the European Patent Office recently communicated its intention to grant to Biolux a patent related to light therapy devices for treatment of bone disorders and biostimulation of bone and soft tissue. The patent specifically relates to Biolux s proprietary devices for extra-oral photobiomodulation of the jaw for dental applications.

Biolux also announces the recent filings of two Patent Cooperation Treaty (PCT) patent applications for new apparatuses and methods for applying photobiomodulation, or light therapy, to orthodontic treatment and related procedures. PCT applications enable patent coverage in all countries that are parties to the treaty, which include all major orthodontic markets.

[click here to download PDF]
December 20, 2011
Biolux Research announces appointment of DR. Tim Shaughnessy to clinical and scientific advisory board

VANCOUVER, B.C., CANADA / Dec. 20, 2011
- Biolux Research Ltd. is pleased to announce the appointment of Timothy G. Shaughnessy, D.D.S., M.S., as consulting orthodontist to Biolux. Dr. Shaughnessy is an American Board of Orthodontics certified orthodontist, a Director of the Atlanta Orthodontic Study Group, and a distinguished presenter having lectured extensively throughout US, Canada, Puerto Rico, and France on Comprehensive Orthodontics. Dr. Shaughnessy studied orthodontics at University of North Carolina School of Dentistry, and has over 25 years of private practice experience in Atlanta, Georgia. www.straightteethdoc.com/

In the role of consulting orthodontist on the Biolux Clinical and Scientific Advisory Board, Dr. Shaughnessy is to review and advise on Biolux's research and development programs, expand the network of orthodontists and beta test sites for clinical evaluation of prototypes and products, and treat a series of cases/patients with the OrthoPulse for clinical evaluation of efficacy and product validation.

[click here to download PDF]
December 14, 2011
Biolux Research Announces New Financing For Development of Light Accelerated Orthodontics Product

VANCOUVER, B.C., CANADA / Dec. 14, 2011
- Biolux Research Ltd. is pleased to announce that it has raised CAD $2.4MM in new funding for the company. The funds were raised through a debt issue that is convertible to common shares at the company's option, and was fully subscribed by existing shareholders of the company.

The proceeds of the financing are designated as working capital to continue the development of the OrthoPulse , a full mouth, extra-oral phototherapy device designed to compliment traditional orthodontic treatment, and facilitate faster tooth movement and reduced treatment timelines. The funds are also targeted to complete initial orthodontic human trials and expand the clinical roadmap of new studies and trials, and to develop new technology and additional intellectual property. The new funds are anticipated to support the company through to the commercial launch of the OrthoPulse .

[click here to download PDF]
August 19, 2011
Biolux Research Announces Start of Significant Series of Clinical Trials for Light-Accelerated Orthodontics.

VANCOUVER, B.C., CANADA - August 19, 2011
-
Biolux Research Ltd. is pleased to announce the start of a series of significant clinical trials to evaluate the effects of our proprietary Light Accelerated Orthodontics technology on the rates of orthodontic tooth movement plus related orthodontic issues.

The principal investigator for the study is Dr. Enis Guray at the Department of Orthodontics, Faculty of Dentistry, Erciyes University, Kayseri, Turkey. Dr. Guray and his team have been investigating the use of the Biolux light treatment, or photobiomodulation, technology in animal and human models for a range of orthodontic applications, and have published an article in the European Journal of Orthodontics, as previously reported.

[click here to download PDF]
March 4, 2011
Biolux Research Announces Start of Key Clinical Trial for Light-Accelerated Orthodontics.

VANCOUVER, B.C., CANADA - March 4, 2011
-
Biolux Research Ltd. is pleased to announce the start of a clinical trial at Mahidol University in Bangkok, Thailand, to evaluate the effects of our phototherapy technology on orthodontic tooth movement and treatment timelines.

The principal investigator for the study is Dr Peerapong Santiwong DDS, PhD (Dental Science), a distinguished researcher and lecturer in orthodontics. Also participating in the study is Dr. Amornpong Vachiramon DDS, DBA, MSc (Maxillofacial Surgery), MSc (Orthodontics), Grad.Dip.Clin.Sc. (Oral Surg), an internationally renowned lecturer and leader in developing new clinical orthodontic protocols and systems. Mahidol University has continuously strived for educational excellence, outstanding research, leadership in healthcare services, and global outlook. Mahidol University's particular strength lies in its research excellence, and its Department of Orthodontics is renowned for the quality of its research. Ethics approval has been granted for the study by the institution.

[click here to download PDF]
January 26, 2011
Biolux Research Announces Publication 0f Research Paper on Phototherapy and Orthodontics.

VANCOUVER, B.C., CANADA - January 26, 2011
-
Biolux Research Ltd. is pleased to announce the publication of a new research paper in the European Journal of Orthodontics. The paper, entitled Resonance frequency analysis of orthodontic miniscrews subjected to light-emitting diode photobiomodulation therapy, was published in December 2010. The principal investigator for the study was Dr. Enis Guray at the Department of Orthodontics, Faculty of Dentistry, Erciyes University, Kayseri, Turkey. Dr. Guray and his team have been investigating the effects of the Biolux OsseoPulse™ LED photobiomodulation (e.g. light treatment) device in various animal and human models for a range of orthodontic applications.

[click here to download PDF]
January 13, 2011
Biolux Research Announces Filing of Two Additional Patent Applications for Phototherapy and Orthodontics.

VANCOUVER, B.C., CANADA - January 13, 2011
-
Biolux Research Ltd. is pleased to announce the filing of two new US patent applications for the use of phototherapy in orthodontics. The applications relate to innovative methods and apparatuses for the use of light treatment technology in combination with advanced and alternative methods of orthodontic treatment, resulting in improved quality, speed, and control of tooth movement.

[click here to download PDF]
December 21, 2010
Biolux Research Announces Start of New Clinical Trial for Light-Accelerated Orthodontics.

VANCOUVER, B.C., CANADA - December 21, 2010
-
Biolux Research Ltd. is pleased to announce the start of a long-term clinical trial to evaluate the effects of Biolux phototherapy technology on orthodontic tooth movement and treatment timelines. The goal of the trial is to evaluate the efficacy of phototherapy over the course of a complete, full mouth orthodontic treatment. The study will include over 40 orthodontic patients treated with traditional brackets and wires plus phototherapy, and the patients will be followed over the course of the treatment program, including post-treatment follow-up. Measures of tooth position and movement will be made periodically by physical measurement and imaging, and secondary measures of procedure acceptance, patient compliance, and product validation will also be collected.

[click here to download PDF]
December 14, 2010
Biolux Research Announces Filing of Patent Application for Phototherapy and Orthodontic Tooth Movement.

VANCOUVER, B.C., CANADA - December 14, 2010
-
Biolux Research Ltd. is pleased to announce the filing of a new US patent application for the use of phototherapy and orthodontics. The invention relates to methods and apparatuses for use in orthodontics, and in particular to methods and apparatuses useful for accelerating, controlling or improving the quality of tooth movement during orthodontic treatment when using a range of orthodontic techniques and materials.

[click here to download PDF]
July 16, 2010
Biolux Research Announces Financing For Continued Development of its Light Accelerated Orthodontics Product

VANCOUVER, B.C., CANADA - July 16, 2010
-
Biolux Research Ltd. is pleased to announce that it has recently raised over CAD $1MM as part of a new equity offering of common shares. The funds were raised through a convertible debt mechanism offered to existing shareholders and optionholders of the company in advance of a planned further offering to the broader investment community in the near future.

[click here to download PDF]
June 24, 2010
Biolux Research Announces Filing of Patent Application for Regulation of Orthodontic Tooth Movement

VANCOUVER, B.C., CANADA - June 24, 2010
-
Biolux Research Ltd. is pleased to announce the filing of a second patent application for a method and apparatus for accelerating and regulating orthodontic tooth movement with light treatment technology. The company filed the application through the Patent Cooperation Treaty process, which will allow for expansion of patent protection to over 200 countries, including all major markets of the world.

[click here to download PDF]
June 10, 2010
Biolux Research Announces Presentation of Accelerated Orthodontic Study Results at International Association for Dental Research General Session 2010

VANCOUVER, B.C., CANADA - June 10, 2010
-
Biolux Research Ltd. is pleased to announce that important results from our accelerated orthodontics research program will be presented at the upcoming International Association for Dental Research (IADR) General Session in Barcelona, Spain, July 14-17, 2010. The IADR is the pre-eminent research organization in the world of dentistry, with a mission to advance research and increase knowledge for the improvement of oral health worldwide, to support and represent the oral health research community, and to facilitate the communication and application of research findings. This year’s meeting will be highly attended by more than 5000 members from all corners of the globe.

[click here to download PDF]
May 10, 2010
Biolux Research announces Presentation of the Osseopulse™ at Ontario Dental Association Annual Spring Meeting 2010

VANCOUVER, B.C., CANADA - May 10, 2010
-
Biolux Research Ltd. is pleased to announce that the OsseoPulse Bone Regeneration System has been selected for presentation in the New Products Forum at the Ontario Dental Association Annual Spring Meeting in Toronto May 13-15, 2010. The presentation will highlight the clinical treatment opportunities with the OsseoPulse™, an innovative light treatment product that stimulates bone regeneration, allowing the dentist to dramatically reduce time to load dental implants and to treat challenging cases with increased confidence. The forum is a classroom setting with interactive discussion, and the presentation is supported by Citagenix Inc, distributor of the OsseoPulse™ in Canada.

[click here to download PDF]
April 26, 2010
Biolux Research announces Design Award for the Osseopulse™ Bone Regeneration System for Implantology

VANCOUVER, B.C., CANADA - April 26, 2010
-
Biolux Research Ltd. is pleased to announce that it has received the prestigious red dot product design award for the OsseoPulse™ Bone Regeneration System, in recognition of the innovative design of the medical product.

[click here to download PDF]
November 5, 2009
Biolux Research announces financing and investigational testing authorization for the development of a light accelerated orthodontics product

VANCOUVER, B.C., CANADA - November 5, 2009
-
Biolux Research Ltd. is pleased to announce that it has issued $860,000 in new shares as part of a new equity offering of common shares.

The offering included a debt conversion vehicle to convert shareholder loans, in which the principle shareholders of the company converted the majority of promissory notes into new shares. The majority of the offering was purchased by Elac Venture Corporation, a private equity investing firm based in Hong Kong. The remainder of the offering was purchased by existing shareholders and individual investors.

[click here to download PDF]
August 13, 2009
Biolux Research announces support from the National Research Council of Canada Industrial Research Assistance Program for the development of light accelerated orthodontics product.

VANCOUVER, B.C., CANADA - Aug. 13, 2009
-
Biolux Research Ltd. is pleased to announce that it has received a non-repayable financial contribution from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to help accelerate the development and commercialization of a new light treatment device for orthodontics. The new product will be designed to significantly accelerate tooth movement during orthodontic treatment, and thus radically reduce treatment times and improve the experience for patients.

NRC-IRAP will contribute approximately CAD $205,000 over the next 18 months to support the research and prototyping of the device, to clinically test and validate the effectiveness of the technology, and to develop a high quality, manufacturable product. In addition to the contribution, NRC-IRAP will provide both technical and business oriented advisory services.

[click here to download PDF]
June 26, 2009
Biolux Research Announces OsseoPulse™ Production Milestone and Expanding Distribution.

VANCOUVER, B.C., CANADA - Jun. 26, 2009
-
Biolux Research Ltd. is pleased to announce today that we have achieved a production milestone for our OsseoPulse™ Bone Regeneration System, and have expanded our product distribution into additional markets.

Since launching the OsseoPulse™ in Canada in Oct. 2008, we have received regulatory clearance in Canada, Korea, Israel, and Europe. Achieving CE Mark is a significant achievement as it provides direct regulatory approval for approximately 20 European countries.

[click here to download PDF]
June 15, 2009
Biolux Research Announces Filing of Patent Application for Light Accelerated Orthodontics.

VANCOUVER, B.C., CANADA - Jun. 15, 2009
-
Biolux Research Ltd. is pleased to announce today the filing of a patent application for a method and apparatus for accelerating orthodontics with light treatment technology.

Orthodontics is the dentistry specialty of moving teeth within the jaw to provide better alignment and other benefits, and is a very common dental procedure. There are approximately 10,000 orthodontists in the US and Canada, with approximately 2 million patients undergoing orthodontic treatment in an average year. Orthodontic treatment is traditionally achieved with appliances (braces) that provide physical force to the teeth and move the roots through the bone. Typical orthodontic treatments range from 12 to 36 months, due to the natural limitations of bone resorption and regeneration processes, and consist of frequent visits to the orthodontist for adjustments and tightening. Reducing overall treatment time can provide a much better experience for the patient, including less social stigma, discomfort, and change of diet, while accelerating the process presents new opportunities to the orthodontist to provide different and better care.

[click here to download PDF]
March 18, 2009
Biolux Research Announces European Launch of the OsseoPulse Bone Regeneration System.

VANCOUVER, B.C., CANADA - Mar. 18, 2009
- Biolux Research Ltd. is pleased to announce today that it will be launching the OsseoPulse Bone Regeneration System at the 33rd International Dental Show from Mar. 24 - 29. http://english.ids-cologne.de/ IDS 2009 in Cologne, Germany is the world's leading trade show and sector meeting place for decision-makers from dental practices, dental labs, the specialist dental trade, the dental industry and from research and development. More than 100,000 visitors gather information on new products and innovations from some 1,750 exhibitors from 55 countries.

Launch of the OsseoPulse™ in Europe builds on recent milestones of achieving both ISO 13485 certification and CE Mark regulatory approval for the product. The CE Mark allows Biolux to market the device directly to the 27 countries within the European Union plus the additional 4 countries that recognize the CE Mark. The dental implant market in Europe represents approximately 40% of the worldwide implant market, and is thus a significant market for Biolux and the OsseoPulse™.

[click here to download PDF]
February 5, 2009
Biolux Research Announces ISO 13485 Quality System Certification and CE Mark Regulatory Approval of the OsseoPulse Bone Regeneration System.

VANCOUVER, B.C., CANADA - Feb. 5, 2009
- Biolux Research Ltd. is pleased to announce today two news items that will further enhance the commercialization of its OsseoPulse Bone Regeneration System.


The company has successfully completed its ISO 13485 certification audit and has been awarded a final certificate. ISO 13485 is a worldwide-recognized medical device quality system standard, and certification to this standard is a requirement for any medical device company to develop, manufacture, and market products in Europe, Canada, and other markets. The Biolux quality system was audited by BSI Management Systems America Inc., one of the foremost auditing bodies in the world.

[click here to download PDF]
December 1, 2008
Biolux Research Announces Commercial Launch of the OsseoPulse Bone Regeneration System in Korea.

VANCOUVER, B.C., CANADA – Dec. 1, 2008 – Biolux Research Ltd. is pleased to announce today that it has launched the OsseoPulse Bone Regeneration System in South Korea. The product is now available for sale exclusively through DIO Implant Inc., a division of publicly-traded Dong Seo Inc, under the distribution agreement signed earlier in 2008. The product has been approved by the Korean FDA as a Class II device, and product has been shipped to DIO to begin marketing and sales of the OsseoPulse to luminaries and opinion leaders.


[click here to download PDF]
October 31, 2008
Biolux Research Announces Launch of the OsseoPulse™ Bone Regeneration System in Canada.

VANCOUVER, B.C., CANADA – Oct. 31, 2008 – Biolux Research Ltd. is pleased to announce today that it has launched the OsseoPulse Bone Regeneration System in Canada. The product is now available for sale through Citagenix Inc., our exclusive distribution partner. The product has been approved by Health Canada as a class II medical device, and received a medical device license earlier in 2008. Production quality has been proven, sales training has taken place, and product has been shipped to Citagenix to begin marketing and sales.


[click here to download PDF]
August 20, 2008
Biolux Research Announces Appointment of Dr. Cameron Clokie as Chair of Scientific Advisory Board.

VANCOUVER, B.C., CANADA August 20, 2008 - Biolux Research Ltd. Is very pleased to announce that it has appointed Dr. Cameron Clokie, DDS, OMFS, PhD, as Chair of its Scientific Advisory Board (SAB). Dr. Clokie is renowned in the field of implantology, and was part of the pioneering group to develop the clinical field in Canada decades ago. For the past ten years Dr. Clokie served as Head of Oral and Maxillofacial Surgery, Faculty of Dentistry, University of Toronto, and is currently a partner at very successful private practice in Toronto. Dr. Clokie has also successfully commercialized numerous dental products in the tissue regeneration space.


[click here to download PDF]
July 24, 2008
Biolux Research Announces Agreement with Citagenix for Exclusive Distribution of the OsseoPulse Bone Regeneration System in Canada.

VANCOUVER, B.C., CANADA July 24, 2008 - Biolux Research Ltd. announced today that it has signed a new distribution agreement with Citagenix Inc. to commercialize the OsseoPulse Bone Regeneration System in Canada. The agreement provides exclusivity and a long term commitment necessary to introduce the new product to the Canadian dental market.


[click here to download PDF]
May 7, 2008
Biolux Research Announces Health Canada Regulatory Approval for its OsseoPulse™
Bone Regeneration System.


VANCOUVER, B.C., CANADA - May 7, 2008 – Biolux Research Ltd. announced today that it has received approval from Health Canada to market the OsseoPulse™ Bone Regeneration System in Canada. The OsseoPulse™ is classified by Health Canada as a Class II medical device, and received a Medical Device Licence for the system and its components. The licence was applied for in partnership with StarFish Medical of Victoria, BC.


[click here to download PDF]
April 4, 2008
Biolux Research Announces Appointment of President and CEO for Commercialization
of its OsseoPulse™ Bone Regeneration System.


VANCOUVER, B.C., CANADA. - April 4, 2008 Biolux Research Ltd. announced today that it has appointed medical device industry veteran Kevin Strange as President and CEO. Mr. Strange’s primary responsibilities will be to lead the commercialization of the unique OsseoPulse™ Bone Regeneration System for dentistry, including product launch into Canada, the US, and Europe, as well as executing work in Korea with our strategic partner DIO Implant, subsidiary of a publicly listed medical device manufacturer and distributor. Dr. Peter Brawn, Chairman and Founder of Biolux, will continue the key roles of clinical and scientific visionary and early product research and development.

[click here to download PDF]
 
 
September 22, 2007
Biolux Research Announces Memorandum of Understanding with Dong Seo Inc. of South Korea
for its OsseoPulse™ Bone Regeneration System.


VANCOUVER, B.C., CANADA. - September 18, 2007 Biolux Research Ltd. announced today that it has signed a Memorandum of Understanding (MOU) with DIO Implant, a wholly owned subsidiary of Dong Seo Inc, which in turn is a KOSDAQ stock exchange listed company and one of Korea’s leading dental implant manufacturers. The MOU is for the purpose of product evaluation, marketing and completion of an exclusive distribution agreement for the OsseoPulse™ dental bone regeneration system in South Korea.

[click here to download PDF]
 
 
Copyright © 2004 - 2014Biolux Research Ltd. All rights reserved. Terms of UsePrivacy PolicyContact Us